PTEN Anti-Oncogene Influences on Neuronal Function & Toxicity
PTEN 抗癌基因对神经元功能的影响
基本信息
- 批准号:7103471
- 负责人:
- 金额:$ 14.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-15 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs diseasePC12 cellsParkinson&aposs diseaseaginganimal old ageapoptosisbiological signal transductioncell growth regulationcytotoxicitydisease /disorder modelgene expressiongenetic regulationgenetically modified animalshydrolasejuvenile animallaboratory mouseneural degenerationneurogeneticsneuropathologyneuroregulationneurotoxicologyneurotoxinsphosphoprotein phosphataseprotein structure functiontumor suppressor proteins
项目摘要
DESCRIPTION (provided by applicant): The PTEN anti-oncogene is among the most frequently mutated genes in malignant brain tumors. Normally, PTEN is a lipid phosphatase which blocks malignant phenotypes primarily by inhibiting the PI3 Kinase/AKT pathways, but PTEN can also act as a protein phosphatase. PTEN is expressed in brain late in development, and neuronal expression continues throughout adult life. Although loss of PTEN can cause neuronal hyperplasia, little is known about the role of PTEN in neuronal development or in normal neurons. Pathways influenced by PTEN suggest that this anti-oncogene may increase neuronal sensitivity to toxicity and/or degenerative processes, which is supported by our preliminary data. This proposal will first determine whether PTEN can modulate sensitivity of cultured neuron-like cells to toxins used in models of Alzheimer's disease and Parkinson's disease. While studying this hypothesis, we have unexpectedly found that PTEN blocks NGF signaling in PC12 cells, and this appears to be at least partially due to inhibition of expression of trkA and p75 NGF receptors at the protein and mRNA levels. DNA microarray then revealed that PTEN can inhibit expression of several genes, including tyrosine hydroxylase and GTP cyclohydrolase
1. Since this may also have implications for neuronal function and for Parkinson's disease, the second Aim of this proposal will also explore the mechanism by which PTEN inhibits expression of these genes. The final Aim of this proposal will explore the effect of age and neurotoxins used in models of neurodegenerative disorders on PTEN levels and function to determine the biological relevance of data generated from the first two Aims. These studies and my development as an independent clinical scientist will be significantly advanced by Dr. M. Flint Beal, who will serve as my sponsor and who is a leading expert in neuronal degeneration in PD and AD. Additional mentoring by Dr. Eric Holland, a leading expert on anti-oncogene signal transduction, will also add significantly to my scientific growth and will also help me to realize many of the Specific Aims of this proposal. The environment at Cornell and the strong support of my institution will permit me to focus upon these studies with minimal distractions. My scientific background is substantial, and this will facilitate realization of the goal of this project. This plan outlined in this award will, however, enhance previously underserved aspects of my education while focusing on an important scientific question, in order to promote a successful transition to scientific independence.
描述(由申请人提供):PTEN抗癌基因是恶性脑肿瘤中最常见的突变基因之一。通常,PTEN是一种脂质磷酸酶,主要通过抑制PI3激酶/AKT途径来阻断恶性表型,但PTEN也可以充当蛋白质磷酸酶。 PTEN在发育后期在大脑中表达,神经元表达在整个成人生活中持续。尽管PTEN的丧失会引起神经元增生,但对PTEN在神经元发育或正常神经元中的作用知之甚少。受PTEN影响的途径表明,这种抗癌基因可能会增加对毒性和/或退化过程的神经元敏感性,这得到了我们的初步数据的支持。该提案将首先确定PTEN是否可以调节培养的神经元样细胞对阿尔茨海默氏病和帕金森氏病模型中使用的毒素的敏感性。在研究这一假设的同时,我们出乎意料地发现PTEN会阻止PC12细胞中的NGF信号传导,这似乎至少部分是由于抑制了TRKA和P75 NGF受体在蛋白质和mRNA水平上的表达。 DNA微阵列随后揭示了PTEN可以抑制几种基因的表达,包括酪氨酸羟化酶和GTP环氢酶
1。由于这也可能对神经元功能和帕金森氏病具有影响,因此该提案的第二个目的还将探索PTEN抑制这些基因表达的机制。该提案的最终目的将探讨在PTEN级别和功能上使用神经退行性疾病模型中使用的年龄和神经毒素的作用,以确定前两个目标产生的数据的生物学相关性。这些研究以及我作为独立临床科学家的发展将由M. Flint Beal博士大大提高,他将担任我的赞助商,并且是PD和AD中神经元退化的领先专家。抗癌基因信号转导专家埃里克·霍兰德(Eric Holland)的额外指导也将大大增加我的科学增长,还将帮助我实现该提案的许多具体目标。康奈尔(Cornell)的环境以及我机构的大力支持将使我能够以最少的干扰专注于这些研究。我的科学背景是实质的,这将有助于实现该项目的目标。但是,该奖项中概述的该计划将增强我的教育中以前服务不足的方面,同时着眼于一个重要的科学问题,以促进成功过渡到科学独立性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL G KAPLITT其他文献
MICHAEL G KAPLITT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL G KAPLITT', 18)}}的其他基金
Neuroprotection via XIAP gene therapy in Huntington's disease
通过 XIAP 基因治疗对亨廷顿病进行神经保护
- 批准号:
7230084 - 财政年份:2006
- 资助金额:
$ 14.58万 - 项目类别:
Neuroprotection via XIAP gene therapy in Huntington's disease
通过 XIAP 基因治疗对亨廷顿病进行神经保护
- 批准号:
7076473 - 财政年份:2006
- 资助金额:
$ 14.58万 - 项目类别:
PTEN Anti-Oncogene Influences on Neuronal Function & Toxicity
PTEN 抗癌基因对神经元功能的影响
- 批准号:
6937259 - 财政年份:2004
- 资助金额:
$ 14.58万 - 项目类别:
PTEN Anti-Oncogene: Neuronal Function and Toxicity
PTEN 抗癌基因:神经元功能和毒性
- 批准号:
6821785 - 财政年份:2004
- 资助金额:
$ 14.58万 - 项目类别:
PTEN Anti-Oncogene Influences on Neuronal Function & Toxicity
PTEN 抗癌基因对神经元功能的影响
- 批准号:
7391290 - 财政年份:2004
- 资助金额:
$ 14.58万 - 项目类别:
相似国自然基金
基于脑-脊髓-视神经MRI影像特征的神经免疫疾病影像亚型及其分子生物学机制的多组学研究
- 批准号:82330057
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
间质性肺疾病致肺气体交换功能改变的超极化129Xe MRI定量研究
- 批准号:82372150
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
缺血性脑卒中疾病中NLRP6磷酸化修饰的鉴定及其在调控炎性小体活化中的作用和机制研究
- 批准号:82302474
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
小胶质细胞清除后骨髓移植延缓csf1r点突变小鼠疾病进展的机制研究
- 批准号:82301526
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
数据驱动的心血管疾病区域协同医疗服务研究
- 批准号:72301123
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Targeting the alpha secretase ADAM10 for the treatment of Alzheimer's disease
靶向 α 分泌酶 ADAM10 治疗阿尔茨海默病
- 批准号:
10590899 - 财政年份:2022
- 资助金额:
$ 14.58万 - 项目类别:
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
用于治疗 ALS 和其他神经退行性疾病的新型蛋白质聚集抑制剂和上运动神经元稳定剂
- 批准号:
10624425 - 财政年份:2019
- 资助金额:
$ 14.58万 - 项目类别:
Identification of neurotrophic extracellular vesicles
神经营养性细胞外囊泡的鉴定
- 批准号:
9765756 - 财政年份:2019
- 资助金额:
$ 14.58万 - 项目类别: